KSM66 is one of the world's most widely used herbal supplements and the world's most widely used and studied ashwagandha. This safety assessment is based on 1) the results of 39 clinical efficacy and safety studies of which 26 are published and 13 are under review for publication 2) the results of 15 preclinical safety studies of which 10 are published and 5 are under review 3) a yearly consumption of 2.5 billion daily doses outside India. The studies show that KSM66 has a clear effect and that the risk profile is identical to placebo. Nearly 4000 people have been included in the studies, the adverse events in the KSM66 group were 3.91% versus 4.77% in the placebo group. All side effects were mild and transient.

On TV4 on December 1, 2024, Professor Martin Bergö claimed that ashwagandha, like most supplements, can cause serious liver side effects. But this is not true. Not if the supplement, like KSM66, contains a pure and organic full-spectrum extract of ashwagandha root. However, one should be careful with the above-ground parts of ashwagandha because the leaves, stem and berries may contain substances that are hepatotoxic, cytotoxic or endocrine disruptors. Professor Bergö was probably unaware of this difference. 36 clinical studies in humans and 13 safety studies in animals show that KSM66 is safe and effective, and that the risk of an adverse reaction is as rare with KSM66 as with a placebo (inactive substance) - and that all adverse reactions were mild and transient.

Below is a summary of facts showing that the risks presented in the article are not applicable to KSM66 - the world's most studied ashwagandha root extract. A food supplement whose efficacy and safety has been proven in 36 clinical studies.

The Indian Health Department (Ministry of Ayush, Government of India) has published a thorough review of the safety of Ashwagandha root. The Expert Safety Report is authored by 18 specialists, doctors, and professors and is a summary of the many hundreds of published studies on Ashwagandha root up to June 2024. The report is a response to the incorrect risk assessment made in Denmark in 2020.

In May2020, the Danish National Food Agency (DTU) published a safety report that concluded that ashwagandha could induce abortion. As the main source, DTU cited a monograph from the WHO 2009, which in turn cited AHP 2000. But according to AHP, the quote from the WHO was not correct. Both AHP and The Botanical Safety Handbook (BSH 2023) now state, after a careful review, that there is no traditional use or documentation that ashwagandha root in normal doses could negatively affect pregnancy, on the contrary. For more information, contact Tom Johnsson, head of R&D: +46705949195, tom@medicinegarden.se

After an incorrect risk assessment by the Danish National Food Administration regarding the safety of ashwagandha root - where, based on mainly small animal studies on leaves and stems, they incorrectly concluded that ashwagandha root can have negative effects, we have chosen to publish a complete safety assessment of KSM66. The most used and clinically studied ashwagandha in the world. For more information, contact Tom Johnsson, head of R&D: +46705949195, tom@medicinegarden.se

This safety report has been prepared in light of the directly erroneous conclusions of a Danish risk assessment of ashwagandha (May 2020(DTU DOCX. No.19/1030299). The safety report clearly shows that the Danish risk assessment of ashwagandha is not applicable to KSM66. The world's most widely used and well-documented ashwagandha. For more information contact Tom Johnsson, 0705 949195, tom@medicinegarden.se

Vitafood's Insight has published a very initiated article that highlights inaccuracies in the risk assessment that DTU has made regarding ashwagandha. For more information, contact Tom Johnsson, head of R&D: +46705949195, tom@medicinegarden.se

The cellulose we use in our products is not cellulose gum (CMC E466) but HPMC E464. An organically approved cellulose with a completely different molecular structure and thus with completely different properties.

Ethylene oxide - an EU unauthorized substance is used by some less serious players in Asia to counteract mold infestation, as a result ETO is sometimes found in Swedish foods and supplements. It's reassuring to know that KSM66 and curaMIN, both originating in India, are produced with 100% control - from seed to finished extract. Each batch (manufacture) is analyzed for possible contaminants, including ETO. So we know that our products are guaranteed to be free of ETO.

The study shows that 2x300 mg of KSM66 (normal dose) effectively reduces cortisol levels in stressed people with elevated cortisol levels. The study also shows that the increased stress tolerance reduces anxiety and improves sleep quality. For the first time, two doses were compared. The conclusion is that the previously recommended dose of KSM66 is effective and safe.

In September 2019, the first pure sleep study on KSM66 - an organic full spectrum extract of Ashwagandha - was published. The authors' conclusion of the study was that there is no doubt that KSM66 is an effective and natural way to improve sleep onset and sleep quality - something that is emphasized by the high significance.

BCM95, the world's most well-documented pure turmeric extract, provides the same increased joint comfort as the standard treatment but with far fewer side effects.

The participants in the study had an average age of 72 years. According to the treating physicians, everyone in the KSM66 group had an effect - 76% had a very good effect. The corresponding figure in the placebo group was 25%.

Both BCM95 (pure Curcumin) and curaMIN (Curcumin combined with Boswellia) improve joint health. The study of more than 200 people shows that the combination with Boswellia is more effective.